{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,8,17]],"date-time":"2023-08-17T13:28:24Z","timestamp":1692278904593},"reference-count":7,"publisher":"Oxford University Press (OUP)","issue":"1-2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,1,4]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n               <jats:p>The DoD Instruction 6130.03, Volume 2, outlines the retention standards for the U.S. Military, providing guidance on medical conditions and treatments that are disqualifying for all branches of the military. This document states that patients with conditions requiring immunomodulating or immunosuppressant medications do not meet retention standards. Eosinophilic esophagitis is a common, chronic inflammatory disease of the esophagus that typically presents with dysphagia. Although proton pump inhibitors are effective at treating this disease in some cases, swallowed topical steroids are the most frequently used therapy within the DoD. These medications act locally in the esophagus and do not cause systemic side effects typical of oral steroid therapy, including immunosuppression. They are effective at inducing and maintaining disease remission and are generally well tolerated, with minimal side effects. We propose a brief amendment to this document to clarify the language used and avoid inappropriate Medical Evaluation Board referrals.<\/jats:p>","DOI":"10.1093\/milmed\/usab359","type":"journal-article","created":{"date-parts":[[2021,8,28]],"date-time":"2021-08-28T06:00:51Z","timestamp":1630130451000},"page":"35-36","source":"Crossref","is-referenced-by-count":1,"title":["Clarification of Eosinophilic Esophagitis Treatment in the DoD Retention Standards"],"prefix":"10.1093","volume":"187","author":[{"given":"Austin","family":"Gable","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Naval Medical Center San Diego, San Diego, CA 92134, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjamin","family":"Fiore","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Naval Medical Center San Diego, San Diego, CA 92134, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph","family":"Cheatham","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Naval Medical Center San Diego, San Diego, CA 92134, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2021,8,28]]},"reference":[{"issue":"2","key":"2022010618262923300_R1","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.gtc.2014.02.002","article-title":"Epidemiology of eosinophilic esophagitis","volume":"43","author":"Dellon","year":"2014","journal-title":"Gastroenterol Clin North Am"},{"issue":"4","key":"2022010618262923300_R2","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1097\/MOG.0000000000000185","article-title":"Proton pump inhibitor-responsive oesophageal eosinophilia and eosinophilic oesophagitis: more similarities than differences","volume":"31","author":"Eluri","year":"2015","journal-title":"Curr Opin Gastroenterol"},{"issue":"5","key":"2022010618262923300_R3","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1053\/j.gastro.2020.07.039","article-title":"Budesonide orodispersible tablets maintain remission in a randomized, placebo-controlled trial of patients with eosinophilic esophagitis","volume":"159","author":"Straumann","year":"2020","journal-title":"Gastroenterology"},{"issue":"7","key":"2022010618262923300_R4","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1053\/j.gastro.2012.03.001","article-title":"Elimination diet effectively treats eosinophilic esophagitis in adults; food reintroduction identifies causative factors","volume":"142","author":"Gonsalves","year":"2012","journal-title":"Gastroenterology"},{"issue":"1-2","key":"2022010618262923300_R5","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1159\/000357089","article-title":"Eosinophilic esophagitis-treatment of eosinophilic esophagitis with drugs: corticosteroids","volume":"32","author":"Von Arnim","year":"2014","journal-title":"Dig Dis"},{"issue":"4","key":"2022010618262923300_R6","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/civ933","article-title":"Clinical practice guideline for the management of candidiasis: 2016 update by the Infectious Diseases Society of America","volume":"62","author":"Pappas","year":"2015","journal-title":"Clin Infect Dis"},{"key":"2022010618262923300_R7","volume-title":"The Relative Cost-Effectiveness of Retaining versus Accessing Air Force Pilots","author":"Mattock","year":"2019"}],"container-title":["Military Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/milmed\/article-pdf\/187\/1-2\/35\/42076432\/usab359.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/milmed\/article-pdf\/187\/1-2\/35\/42076432\/usab359.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,6]],"date-time":"2022-01-06T18:26:43Z","timestamp":1641493603000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/milmed\/article\/187\/1-2\/35\/6358820"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,28]]},"references-count":7,"journal-issue":{"issue":"1-2","published-online":{"date-parts":[[2021,8,28]]},"published-print":{"date-parts":[[2022,1,4]]}},"URL":"https:\/\/doi.org\/10.1093\/milmed\/usab359","relation":{},"ISSN":["0026-4075","1930-613X"],"issn-type":[{"value":"0026-4075","type":"print"},{"value":"1930-613X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,1,1]]},"published":{"date-parts":[[2021,8,28]]}}}